Eigentler, T., Thomas, I., Samoylenko, I., Erdmann, M., Heinzerling, L., Ochsenreither, S., . . . Gnad-Vogt, U. (2025). Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma. Journal for ImmunoTherapy of Cancer, 13(2), . https://doi.org/10.1136/jitc-2024-009352
Chicago-Zitierstil (17. Ausg.)Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for ImmunoTherapy of Cancer 13, no. 2 (2025). https://doi.org/10.1136/jitc-2024-009352.
MLA-Zitierstil (9. Ausg.)Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for ImmunoTherapy of Cancer, vol. 13, no. 2, 2025, https://doi.org/10.1136/jitc-2024-009352.